Everything to know about the ancient art of hair oiling
From enjoying the benefits of yoga to embracing the traditional methods of
Ayurveda
, we've explored many practices passed down through generations in Indian culture. But if you think you've tried it all, there's one Indian tradition that has quietly woven its way into Western culture, often without due credit.
It's the ancient art of hair oiling, a time-honored ritual deeply rooted in Ayurveda, the 5,000-year-old science of healthy living that originated in India.
Making it one of the oldest healing systems in the world, hair oiling is an ancient practice that involves pouring oil onto your hair and scalp, then gently massaging it, which further deeply nourishes the hair and scalp, boosting overall hair health.
(Image Credits: Pinterest)
The
wisdom of Ayurveda
The wisdom of Ayurveda provides a holistic approach to Indian haircare traditions, which focuses on the interdependence of body, spirit, and mind in order to achieve healthy hair.
By integrating the Ayurvedic concepts into the current haircare regimens, it allows people to nourish their strands with lifestyle practices and natural oil, which then promotes vitality, balance, and long-lasting beauty.
This ageless wisdom of Ayurveda continues to guide and inspire people on the road to having vibrant, voluminous, and healthy locks and is a reflection of India's rich culture, which is deeply rooted in our nature.
5 things you didn't know about liquid hair
Simple benefits of oiling for our hair strands
Provides nourishment and moisture:
Oil penetrates deeply into hair follicles, which gives necessary nutrients that feed and hydrate the hair shaft, further decreasing the dryness and frizz from our strands.
Hair growth and strength:
This process increases the blood circulation to the scalp, which then promotes hair development and strengthens hair roots while decreasing hair loss and breakage issues.
(Image Credits: Pinterest)
Maintains scalp health:
Massaging oil into the scalp improves overall scalp circulation, decreases dandruff issues, soothes inflammation, and promotes a healthy scalp environment.
Provides natural shine and lustre:
Religious use of hair oils gives natural shine and lustre, improving its appearance, which makes it easier to manage overall.
Calms and relaxes the mind:
The act of massaging oil into the scalp overall promotes relaxation, which reduces stress and relieves tension headaches as well.
Develop a personalised approach to hair oil and improve its effectiveness, addressing your scalp and hair demands. The religious process of applying hair oil is not just a haircare treatment but a voyage of self-discovery and development.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
22 minutes ago
- Economic Times
India clears Roche's 7-minute cancer injection Tecentriq for patients, with Phase IV trial condition
Synopsis Roche has received clearance to import and market Atezolizumab injection (Tecentriq) for subcutaneous administration in India, potentially reducing cancer treatment time and costs. The approval, granted by a technical committee, requires Roche to conduct a Phase IV clinical trial in India. This new route offers a faster, more convenient option for patients, with administration possible outside of hospitals. Roche Gets Approval to Import Key Cancer Injection for Domestic Mkt New Delhi: The technical committee constituted for supervising clinical trials on new chemical entities has cleared Swiss drug major Roche to import and market cancer drug Atezolizumab injection (Tecentriq) through subcutaneous (SC) route-under the skin injection for Indian decisions is expected to provide relief to patients in the contry as the new subcutaneous injections will cut treatment time to nearly seven minutes from the 30-60 minutes in the standard intravenous (IV) infusion, besides saving on costs. The panel's permission has been given with a condition that the company would conduct a Phase IV clinical trial in India. "Switching from intravenous (IV) to subcutaneous (SC) administration of Atezolizumab can potentially reduce costs due to decreased healthcare professional time and improved patient convenience," a government official told ET. "Tecentriq may be administered by a healthcare professional outside of the hospital, in a community care setting or at a patient's home," he added. Atezolizumab is an immunotherapy called an immune checkpoint inhibitor, which blocks the immune system's natural brakes to help immune cells fight technical committee under the Director General of Health Services (DGHS) was formed in 2013 following the directions of the Supreme a recent meeting, Roche presented the proposal for grant of permission to import and market the drug product Atezolizumab injection (Tecentriq®) 1875 mg/15 mL vial for subcutaneous administration for the following indications with the request of local Phase III clinical trial waiver and commitment to conduct a Phase IV trial in is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. It is a monotherapy for the first line treatment of patients of metastatic committee noted the pharmacokinetic-pharmacodynamic or PK/PD results of Asian & non-Asian population from the global clinical study for the ethnic differences in the PK parameters in the study. The committee further noted that firm has received the USFDA approval for the SC route on committee also asked the company to submit Phase IV clinical trial protocol to CDSCO within three months of grant of marketing authorisation.
Time of India
34 minutes ago
- Time of India
India clears Roche's 7-minute cancer injection Tecentriq for patients, with Phase IV trial condition
New Delhi: The technical committee constituted for supervising clinical trials on new chemical entities has cleared Swiss drug major Roche to import and market cancer drug Atezolizumab injection ( Tecentriq ) through subcutaneous (SC) route-under the skin injection for Indian patients. The decisions is expected to provide relief to patients in the contry as the new subcutaneous injections will cut treatment time to nearly seven minutes from the 30-60 minutes in the standard intravenous (IV) infusion, besides saving on costs. The panel's permission has been given with a condition that the company would conduct a Phase IV clinical trial in India. "Switching from intravenous (IV) to subcutaneous (SC) administration of Atezolizumab can potentially reduce costs due to decreased healthcare professional time and improved patient convenience," a government official told ET. "Tecentriq may be administered by a healthcare professional outside of the hospital, in a community care setting or at a patient's home," he added. Atezolizumab is an immunotherapy called an immune checkpoint inhibitor, which blocks the immune system's natural brakes to help immune cells fight cancer. The technical committee under the Director General of Health Services (DGHS) was formed in 2013 following the directions of the Supreme Court. In a recent meeting, Roche presented the proposal for grant of permission to import and market the drug product Atezolizumab injection (Tecentriq®) 1875 mg/15 mL vial for subcutaneous administration for the following indications with the request of local Phase III clinical trial waiver and commitment to conduct a Phase IV trial in India. Atezolizumab is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy. It is a monotherapy for the first line treatment of patients of metastatic NSCLC. The committee noted the pharmacokinetic-pharmacodynamic or PK/PD results of Asian & non-Asian population from the global clinical study for the ethnic differences in the PK parameters in the study. The committee further noted that firm has received the USFDA approval for the SC route on 12.09.2024. The committee also asked the company to submit Phase IV clinical trial protocol to CDSCO within three months of grant of marketing authorisation.
Hindustan Times
2 hours ago
- Hindustan Times
Uproar in US as Indian doctor's $800 education cost revelation by X user sparks racist backlash; ‘Poorly trained frauds'
A social media user caused a stir when he disclosed that his Indian doctor had completed his 'entire education' just at $800, sparking a flurry of racist comments. A social media user's revelation about an Indian doctor's $800 education led to racist backlash and claims of inadequacy(Pixabay/ Representational) 'I went to a walk-in, Indian Doctor. He was a young guy. He told me he went to medical school in India, and that his entire education cost about $800.00 Interesting stuff,' one person posted on X. Several people on social media stated that they would have 'walked out' or denied to allow the doctor to treat them after knowing this information. Some other X users compared his education fee to the high costs associated with medical school in America, claiming that his degree was 'fake' and his training was inadequate. Post on India doctor sparks racists comments The post has generated a flurry of unsubstantiated claims and blatant biases, with many Americans calling on the original poster to 'run' from treatment. Many users in the comment section expressed strong racist views, arguing that having such a practitioner was 'unfair to US people, patients, and doctors.' 'That how much certificates cost over there? Crazy,' one user asked, while another wrote: 'They go straight from high school into 'medical school'. The crime is that American law allows these poorly trained frauds to practice here in the states.' 'Went to an Indian dentist. Drilled my tooth, said, 'Oops, I shouldn't have done that', then threw her arms up in the air and walked out, leaving me alone with the hygienist, who had to clean up her mess,' a third user said. Also Read: Alaska in Russia? Trump's embarrassing blunder on upcoming meeting with Putin creates uproar on social media Indian users offer explanation on govt-funded education Meanwhile, some Indian users attempted to explain that the Indian doctor's education might be 'subsidized by the government' in public institutes, adding that 'in other words India taxpayers funded his education.' They clarified that higher education in India is of excellent quality and is supported by the government, stressing that admission to these universities is extremely competitive due to the limited number of seats and the large number of applicants. 'These are considered the best colleges and better than almost all private colleges in India,' another said. 'India doesn't trap it's students under student debts like other countries,' a third Indian user chimed in.
